Topics

Robert H. Bork
Generic drug makers fight rule on health risk warnings
Generic drug makers fight rule on health risk warnings

WASHINGTON — Companies that make generic drugs, the medications most Americans buy, are fighting to kill a proposed federal regulation that would require them for the first time to warn patients of all the known health risks of each drug they sell. The proposed rule change by the Food and Drug Administration "would be nothing short of catastrophic," said Ralph G. Neas, president of the Generic Pharmaceutical Assn., an industry trade group. It could raise healthcare costs and "create dangerous confusion" for doctors and patients, he said. At issue is a legal loophole created by Supreme Court rulings that drew a sharp distinction between brand-name drugs and...

Loading